HEXIMA LTD has a total of 162 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and basic materials chemistry are COOPERATIVE RESEARCH CENTRE FO, FLAGSHIP PIONEERING INNOVATIONS VI LLC and PAUL EHRLICH INST BUNDESAMT FU.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 34 | |
#2 | Australia | 22 | |
#3 | WIPO (World Intellectual Property Organization) | 17 | |
#4 | Canada | 16 | |
#5 | China | 16 | |
#6 | EPO (European Patent Office) | 15 | |
#7 | Brazil | 9 | |
#8 | New Zealand | 9 | |
#9 | Argentina | 5 | |
#10 | Singapore | 5 | |
#11 | Mexico | 4 | |
#12 | South Africa | 4 | |
#13 | Republic of Korea | 2 | |
#14 | Hong Kong | 1 | |
#15 | India | 1 | |
#16 | Japan | 1 | |
#17 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Basic materials chemistry | |
#4 | Environmental technology | |
#5 | Foods and drinks | |
#6 | Measurement | |
#7 | Medical technology | |
#8 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Preservation of human bodies | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Climate change adaptation technologies | |
#7 | New plants | |
#8 | Analysing materials | |
#9 | Object sterilising | |
#10 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Anderson Marilyn Anne | 131 |
#2 | Heath Robyn Louise | 72 |
#3 | Van Der Weerden Nicole | 42 |
#4 | Van Der Weerden Nicole Louise | 28 |
#5 | Poon Simon | 26 |
#6 | Lay Fung Tso | 23 |
#7 | Mckenna James | 10 |
#8 | Mckenna James Anthony | 10 |
#9 | Dunse Kerry Michelle | 9 |
#10 | Marilyn Anne Anderson | 8 |
Publication | Filing date | Title |
---|---|---|
BR112020018675A2 | INSECTICID PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | |
HK1252497A1 | A method of in vivo treatment | |
AU2016333152A1 | A method | |
US2019225652A1 | Generation of peptides | |
SG11201708815UA | A method of in vivo treatment | |
CA2965187A1 | A method of treatment | |
CA2946163A1 | Agents and methods of treatment | |
CN106231899A | For processing reagent and the method for pathogen | |
AU2013350317A1 | Anti-pathogenic methods | |
AU2013260696A1 | Use of anti-fungal defensins | |
AU2013202034A1 | Anti Fungal Methods | |
US2013269059A1 | Anti-Pathogen Systems | |
US2013267459A1 | Anti-pathogen systems | |
KR20140022802A | Modified plant defensins useful as anti-pathogenic agents | |
CA2733267A1 | Plant anti-pathogen systems | |
MX2010008292A | Anti fungal methods. | |
AU2008202250A1 | Insect chymotrypsin and inhibitors thereof | |
WO2008128289A1 | Modified plant defensin | |
NZ580505A | Modified plant defensin comprising a signal peptide, a mature domain from a Class I defensin and a C-terminal propeptide tail from a Class II plant defensin | |
US2007277263A1 | Multi-gene expression vehicle |